Lymphocyte Activation Gene-3 Blocker
DBCAT005804Therapeutic category
A DrugBank category of 1 drug. 1 of them is approved.
- Drugs
What you can answer from here — as of January 14, 2023
Which targets do Lymphocyte Activation Gene-3 Blocker share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account